Effects of exogenous deoxyribonuclease I in collagen antibody-induced arthritis.
Autoimmune disease
Cell-free DNA
Chronic inflammation
Deoxyribonuclease
Journal
Journal of inflammation (London, England)
ISSN: 1476-9255
Titre abrégé: J Inflamm (Lond)
Pays: England
ID NLM: 101232234
Informations de publication
Date de publication:
09 Sep 2024
09 Sep 2024
Historique:
received:
06
06
2023
accepted:
19
08
2024
medline:
10
9
2024
pubmed:
10
9
2024
entrez:
9
9
2024
Statut:
epublish
Résumé
Rheumatoid arthritis (RA) is associated with a high concentration of extracellular DNA (ecDNA). This could be a consequence of the inflammation, but the ecDNA could also be involved in the unknown etiopathogenesis of RA. Clearance of ecDNA is hypothesized to prevent the development of RA. This study aimed to analyze the effects of exogenous deoxyribonuclease I (DNase I) administration in an animal model of RA. The collagen antibody-induced arthritis (CAIA) model of RA was induced in adult female DBA/1J mice. CAIA mice were treated with saline or DNase I (10 mg/kg) every 12 h for the whole duration of the experiment. Arthritic scores were assessed. Paw volume and temperature were assessed using a plethysmometer and a thermal camera, respectively. Plasma ecDNA and its subcellular origin were analyzed using fluorometry and real-time PCR. DNase activity was quantified with single radial enzyme diffusion method. The CAIA model was successfully induced as proved by a higher volume, temperature and the overall arthritis score in comparison to controls. The administration of DNase I resulted in a nearly two-fold increase in serum DNase activity. Still, it did affect neither plasma ecDNA, nor the arthritis score or other measures of joint inflammation. Our results suggest that exogenous DNase I does not prevent the development of CAIA in mice. Whether this is true for other animal models of arthritis or clinical RA requires further research. EcDNA does not seem to be involved in the pathogenesis of CAIA. Additional studies are also needed to elucidate the role of ecDNA in the development of RA, focusing especially on its origin and inhibition of ecDNA release.
Sections du résumé
BACKGROUND
BACKGROUND
Rheumatoid arthritis (RA) is associated with a high concentration of extracellular DNA (ecDNA). This could be a consequence of the inflammation, but the ecDNA could also be involved in the unknown etiopathogenesis of RA. Clearance of ecDNA is hypothesized to prevent the development of RA. This study aimed to analyze the effects of exogenous deoxyribonuclease I (DNase I) administration in an animal model of RA.
METHODS
METHODS
The collagen antibody-induced arthritis (CAIA) model of RA was induced in adult female DBA/1J mice. CAIA mice were treated with saline or DNase I (10 mg/kg) every 12 h for the whole duration of the experiment. Arthritic scores were assessed. Paw volume and temperature were assessed using a plethysmometer and a thermal camera, respectively. Plasma ecDNA and its subcellular origin were analyzed using fluorometry and real-time PCR. DNase activity was quantified with single radial enzyme diffusion method.
RESULTS
RESULTS
The CAIA model was successfully induced as proved by a higher volume, temperature and the overall arthritis score in comparison to controls. The administration of DNase I resulted in a nearly two-fold increase in serum DNase activity. Still, it did affect neither plasma ecDNA, nor the arthritis score or other measures of joint inflammation.
CONCLUSION
CONCLUSIONS
Our results suggest that exogenous DNase I does not prevent the development of CAIA in mice. Whether this is true for other animal models of arthritis or clinical RA requires further research. EcDNA does not seem to be involved in the pathogenesis of CAIA. Additional studies are also needed to elucidate the role of ecDNA in the development of RA, focusing especially on its origin and inhibition of ecDNA release.
Identifiants
pubmed: 39251994
doi: 10.1186/s12950-024-00403-z
pii: 10.1186/s12950-024-00403-z
doi:
Types de publication
Journal Article
Langues
eng
Pagination
36Subventions
Organisme : Agentúra na Podporu Výskumu a Vývoja
ID : APVV-18-0366
Informations de copyright
© 2024. The Author(s).
Références
Smolen JS, Aletaha D, Barton A, Burmester GR, Emery P, Firestein GS, et al. Rheumatoid arthritis. Nat Rev Dis Primers. 2018;4:18001.
pubmed: 29417936
doi: 10.1038/nrdp.2018.1
Burmester GR, Pope JE. Novel treatment strategies in rheumatoid arthritis. Lancet. 2017;389(10086):2338–48.
pubmed: 28612748
doi: 10.1016/S0140-6736(17)31491-5
Smolen JS, Emery P, Fleischmann R, van Vollenhoven RF, Pavelka K, Durez P, et al. Adjustment of therapy in rheumatoid arthritis on the basis of achievement of stable low disease activity with adalimumab plus methotrexate or methotrexate alone: the randomised controlled OPTIMA trial. Lancet. 2014;383(9914):321–32.
pubmed: 24168956
doi: 10.1016/S0140-6736(13)61751-1
Kavanaugh A, van Vollenhoven RF, Fleischmann R, Emery P, Sainsbury I, Florentinus S, et al. Testing treat-to-target outcomes with initial methotrexate monotherapy compared with initial tumour necrosis factor inhibitor (adalimumab) plus methotrexate in early rheumatoid arthritis. Ann Rheum Dis. 2018;77(2):289–92.
pubmed: 29146743
doi: 10.1136/annrheumdis-2017-211871
Rykova E, Sizikov A, Roggenbuck D, Antonenko O, Bryzgalov L, Morozkin E, et al. Circulating DNA in rheumatoid arthritis: pathological changes and association with clinically used serological markers. Arthritis Res Ther. 2017;19(1):85.
pubmed: 28464939
pmcid: 5414163
doi: 10.1186/s13075-017-1295-z
Galluzzi L, Vitale I, Aaronson SA, Abrams JM, Adam D, Agostinis P, et al. Molecular mechanisms of cell death: recommendations of the nomenclature Committee on Cell Death 2018. Cell Death Differ. 2018;25(3):486–541.
pubmed: 29362479
pmcid: 5864239
doi: 10.1038/s41418-017-0012-4
Brinkmann V, Reichard U, Goosmann C, Fauler B, Uhlemann Y, Weiss DS, et al. Neutrophil extracellular traps kill bacteria. Science. 2004;303(5663):1532–5.
pubmed: 15001782
doi: 10.1126/science.1092385
Lee KH, Kronbichler A, Park DD-Y, Park Y, Moon H, Kim H, et al. Neutrophil extracellular traps (NETs) in autoimmune diseases: a comprehensive review. Autoimmun rev. 2017;16(11):1160–73.
pubmed: 28899799
doi: 10.1016/j.autrev.2017.09.012
Sur Chowdhury C, Giaglis S, Walker UA, Buser A, Hahn S, Hasler P. Enhanced neutrophil extracellular trap generation in rheumatoid arthritis: analysis of underlying signal transduction pathways and potential diagnostic utility. Arthritis Res Therapy. 2014;16:1–14.
doi: 10.1186/ar4579
Lichá K, Pastorek M, Repiská G, Celec P, Konečná B. Investigation of the Presence of DNA in human blood plasma small extracellular vesicles. Int J Mol Sci. 2023;24(6).
Kustanovich A, Schwartz R, Peretz T, Grinshpun A. Life and death of circulating cell-free DNA. Cancer Biol Ther. 2019;20(8):1057–67.
pubmed: 30990132
pmcid: 6606043
doi: 10.1080/15384047.2019.1598759
Boyapati RK, Tamborska A, Dorward DA, Ho GT. Advances in the understanding of mitochondrial DNA as a pathogenic factor in inflammatory diseases. F1000Res. 2017;6:169.
pubmed: 28299196
pmcid: 5321122
doi: 10.12688/f1000research.10397.1
Han DSC, Lo YMD. The Nexus of cfDNA and nuclease Biology. Trends Genet. 2021;37(8):758–70.
pubmed: 34006390
doi: 10.1016/j.tig.2021.04.005
Macáková K, Illésová J, Mlynáriková V, Lesayová A, Konečná B, Vlková B, et al. The dynamics of extracellular DNA associates with treatment response in patients with rheumatoid arthritis. Sci Rep. 2022;12(1):21099.
pubmed: 36473902
pmcid: 9726858
doi: 10.1038/s41598-022-23954-8
Lauková L, Konečná B, Vlková B, Mlynáriková V, Celec P, Šteňová E. Anti-cytokine therapy and plasma DNA in patients with rheumatoid arthritis. Rheumatol Int. 2018;38:1449–54.
pubmed: 29796906
doi: 10.1007/s00296-018-4055-8
Hashimoto T, Yoshida K, Hashiramoto A, Matsui K. Cell-free DNA in rheumatoid arthritis. Int J Mol Sci. 2021;22(16).
Gaipl US, Beyer TD, Heyder P, Kuenkele S, Böttcher A, Voll RE, et al. Cooperation between C1q and DNase I in the clearance of necrotic cell-derived chromatin. Arthritis Rheum. 2004;50(2):640–9.
pubmed: 14872509
doi: 10.1002/art.20034
Mathapathi S, Chu C-Q. Contribution of impaired DNASE1L3 activity to anti-DNA autoantibody production in systemic lupus erythematosus. Rheumatol Immunol Res. 2022;3(1):17–22.
pubmed: 36467024
pmcid: 9524810
doi: 10.2478/rir-2022-0003
Sadeghi M, Dehnavi S, Jamialahmadi T, Johnston TP, Sahebkar A. Neutrophil extracellular trap: a key player in the pathogenesis of autoimmune diseases. Int Immunopharmacol. 2023;116:109843.
pubmed: 36764274
doi: 10.1016/j.intimp.2023.109843
Korzeneva IB, Kostuyk SV, Ershova LS, Osipov AN, Zhuravleva VF, Pankratova GV, et al. Human circulating plasma DNA significantly decreases while lymphocyte DNA damage increases under chronic occupational exposure to low-dose gamma-neutron and tritium β-radiation. Mutat Research/Fundamental Mol Mech Mutagen. 2015;779:1–15.
doi: 10.1016/j.mrfmmm.2015.05.004
Shak S, Capon DJ, Hellmiss R, Marsters SA, Baker CL. Recombinant human DNase I reduces the viscosity of cystic fibrosis sputum. Proc Natl Acad Sci. 1990;87(23):9188–92.
pubmed: 2251263
pmcid: 55129
doi: 10.1073/pnas.87.23.9188
Lazarus RA, Wagener JS. Recombinant human deoxyribonuclease I. Pharmaceutical biotechnology: fundamentals and applications. 2019:471 – 88.
Kmeťová K, Čonka J, Janko J, Illés J, Uličná O, Celec P. Plasma DNA and deoxyribonuclease are associated with glucose metabolism in healthy mice. PLoS ONE. 2022;17(4):e0265099.
pubmed: 35385497
pmcid: 8985945
doi: 10.1371/journal.pone.0265099
Vokálová L, Lauková L, Čonka J, Melišková V, Borbélyová V, Bábíčková J, et al. Deoxyribonuclease partially ameliorates thioacetamide-induced hepatorenal injury. Am J Physiol Gastrointest Liver Physiol. 2017;312(5):G457–63.
pubmed: 28209603
doi: 10.1152/ajpgi.00446.2016
Kumar R, Sonkar VK, Swamy J, Ahmed A, Sharathkumar AA, Pierce GL, et al. DNase 1 protects from increased thrombin generation and venous thrombosis during Aging: cross-sectional study in mice and humans. J Am Heart Association. 2022;11(2):e021188.
doi: 10.1161/JAHA.121.021188
Peer V, Abu Hamad R, Berman S, Efrati S. Renoprotective effects of DNAse-I Treatment in a rat model of Ischemia/Reperfusion-Induced Acute kidney Injury. Am J Nephrol. 2016;43(3):195–205.
pubmed: 27073834
doi: 10.1159/000445546
Wang N, Ma J, Song W, Zhao C. An injectable hydrogel to disrupt neutrophil extracellular traps for treating rheumatoid arthritis. Drug Delivery. 2023;30(1):2173332.
pubmed: 36724178
pmcid: 9897762
doi: 10.1080/10717544.2023.2173332
Cantley MD, Haynes DR, Marino V, Bartold PM. Pre-existing periodontitis exacerbates experimental arthritis in a mouse model. J Clin Periodontol. 2011;38(6):532–41.
pubmed: 21434962
doi: 10.1111/j.1600-051X.2011.01714.x
Vetal S, Bodhankar SL, Mohan V, Thakurdesai PA. Anti-inflammatory and anti-arthritic activity of type-A procyanidine polyphenols from bark of Cinnamomum zeylanicum in rats. Food Sci Hum Wellness. 2013;2(2):59–67.
doi: 10.1016/j.fshw.2013.03.003
Vogel B, Wagner H, Gmoser J, Wörner A, Löschberger A, Peters L, et al. Touch-free measurement of body temperature using close-up thermography of the ocular surface. MethodsX. 2016;3:407–16.
pubmed: 27284532
pmcid: 4887592
doi: 10.1016/j.mex.2016.05.002
Nosrati Z, Bergamo M, Rodríguez-Rodríguez C, Saatchi K, Häfeli UO. Refinement and validation of infrared thermal imaging (IRT): a non-invasive technique to measure disease activity in a mouse model of rheumatoid arthritis. Arthritis Res Therapy. 2020;22:1–16.
doi: 10.1186/s13075-020-02367-w
Gutowski MB, Wilson L, Van Gelder RN, Pepple KL. In vivo bioluminescence imaging for longitudinal monitoring of inflammation in animal models of uveitis. Investig Ophthalmol Vis Sci. 2017;58(3):1521–8.
doi: 10.1167/iovs.16-20824
Hayer S, Vervoordeldonk MJ, Denis MC, Armaka M, Hoffmann M, Bäcklund J, et al. SMASH’recommendations for standardised microscopic arthritis scoring of histological sections from inflammatory arthritis animal models. Ann Rheum Dis. 2021;80(6):714–26.
pubmed: 33602797
doi: 10.1136/annrheumdis-2020-219247
Lo YD, Corbetta N, Chamberlain PF, Rai V, Sargent IL, Redman CW, et al. Presence of fetal DNA in maternal plasma and serum. Lancet. 1997;350(9076):485–7.
pubmed: 9274585
doi: 10.1016/S0140-6736(97)02174-0
Janovičová Ľ, Čonka J, Lauková L, Celec P. Variability of endogenous deoxyribonuclease activity and its pathophysiological consequences. Mol Cell Probes. 2022:101844.
Duvvuri B, Lood C. Cell-free DNA as a Biomarker in Autoimmune Rheumatic diseases. Front Immunol. 2019;10:502.
pubmed: 30941136
pmcid: 6433826
doi: 10.3389/fimmu.2019.00502
Lauková L, Konečná B, Bábíčková J, Wagnerová A, Melišková V, Vlková B, et al. Exogenous deoxyribonuclease has a protective effect in a mouse model of sepsis. Biomed Pharmacother. 2017;93:8–16.
pubmed: 28622595
doi: 10.1016/j.biopha.2017.06.009
Zervou MI, Andreou A, Matalliotakis M, Spandidos DA, Goulielmos GN, Eliopoulos EE. Association of the DNASE1L3 rs35677470 polymorphism with systemic lupus erythematosus, rheumatoid arthritis and systemic sclerosis: structural biological insights. Mol Med Rep. 2020;22(6):4492–8.
pubmed: 33173951
pmcid: 7646740
doi: 10.3892/mmr.2020.11547
Kawane K, Ohtani M, Miwa K, Kizawa T, Kanbara Y, Yoshioka Y, et al. Chronic polyarthritis caused by mammalian DNA that escapes from degradation in macrophages. Nature. 2006;443(7114):998–1002.
pubmed: 17066036
doi: 10.1038/nature05245
Choudhary N, Bhatt LK, Prabhavalkar KS. Experimental animal models for rheumatoid arthritis. Immunopharmacol Immunotoxicol. 2018;40(3):193–200.
pubmed: 29433367
doi: 10.1080/08923973.2018.1434793
Schuh BM, Macáková K, Feješ A, Groß T, Belvončíková P, Janko J et al. Sex differences in long-term effects of collagen-induced arthritis in middle-aged mice. Front Physiol.14:1195604.
Knight JS, Carmona-Rivera C, Kaplan MJ. Proteins derived from neutrophil extracellular traps may serve as self-antigens and mediate organ damage in autoimmune diseases. Front Immunol. 2012;3:380.
pubmed: 23248629
pmcid: 3521997
doi: 10.3389/fimmu.2012.00380
Wright HL, Lyon M, Chapman EA, Moots RJ, Edwards SW. Rheumatoid arthritis synovial fluid neutrophils drive inflammation through production of chemokines, reactive oxygen species, and neutrophil extracellular traps. Front Immunol. 2021;11:3364.
doi: 10.3389/fimmu.2020.584116
Metzemaekers M, Malengier-Devlies B, Yu K, Vandendriessche S, Yserbyt J, Matthys P, et al. Synovial fluid neutrophils from patients with juvenile idiopathic arthritis display a hyperactivated phenotype. Arthritis Rheumatol. 2021;73(5):875–84.
pubmed: 33264510
doi: 10.1002/art.41605
Varady NH, Schwab P-E, Kheir MM, Dilley JE, Bedair H, Chen AF. Synovial fluid and serum neutrophil-to-lymphocyte ratio: novel biomarkers for the diagnosis and prognosis of native septic arthritis in adults. JBJS. 2022;104(17):1516–22.
doi: 10.2106/JBJS.21.01279
Zhang L, Yuan Y, Xu Q, Jiang Z, Chu C-Q. Contribution of neutrophils in the pathogenesis of rheumatoid arthritis. J Biomedical Res. 2020;34(2):86.
doi: 10.7555/JBR.33.20190075
Schneider AH, Taira TM, Públio GA, da Silva Prado D, Donate Yabuta PB, Dos Santos JC, et al. Neutrophil extracellular traps mediate bone erosion in rheumatoid arthritis by enhancing RANKL-induced osteoclastogenesis. Br J Pharmacol. 2024;181(3):429–46.
pubmed: 37625900
doi: 10.1111/bph.16227
O’Neil LJ, Barrera-Vargas A, Sandoval-Heglund D, Merayo-Chalico J, Aguirre-Aguilar E, Aponte AM, et al. Neutrophil-mediated carbamylation promotes articular damage in rheumatoid arthritis. Sci Adv. 2020;6(44):eabd2688.
pubmed: 33115748
pmcid: 7608797
doi: 10.1126/sciadv.abd2688
Wilson AS, Randall KL, Pettitt JA, Ellyard JI, Blumenthal A, Enders A, et al. Neutrophil extracellular traps and their histones promote Th17 cell differentiation directly via TLR2. Nat Commun. 2022;13(1):528.
pubmed: 35082281
pmcid: 8792063
doi: 10.1038/s41467-022-28172-4
Hashimoto T, Yoshida K, Hashimoto N, Nakai A, Kaneshiro K, Suzuki K, et al. Circulating cell free DNA: a marker to predict the therapeutic response for biological DMARDs in rheumatoid arthritis. Int J Rheum Dis. 2017;20(6):722–30.
pubmed: 27943573
doi: 10.1111/1756-185X.12959
Phillipson M, Kubes P. The neutrophil in vascular inflammation. Nat Med. 2011;17(11):1381–90.
pubmed: 22064428
pmcid: 7095830
doi: 10.1038/nm.2514
Radic M, Muller S. LL-37, a multi-faceted amphipathic peptide involved in NETosis. Cells. 2022;11(15).
Van Holde K, Allen J, Tatchell K, Weischet W, Lohr D. DNA-histone interactions in nucleosomes. Biophys J. 1980;32(1):271–82.
pubmed: 6788105
pmcid: 1327304
doi: 10.1016/S0006-3495(80)84956-3
Hakkim A, Fürnrohr BG, Amann K, Laube B, Abed UA, Brinkmann V et al. Impairment of neutrophil extracellular trap degradation is associated with lupus nephritis. Proceedings of the National Academy of Sciences. 2010;107(21):9813-8.
Puccetti A, Madaio MP, Bellese G, Migliorini P. Anti-DNA antibodies bind to DNase I. J Exp Med. 1995;181(5):1797–804.
pubmed: 7722456
doi: 10.1084/jem.181.5.1797